A long-term glycyrrhizin injection therapy reduces hepatocellular carcinogenesis rate in patients with interferon-resistant active chronic hepatitis C: a cohort study of 1249 patients. [electronic resource]
Producer: 20060517Description: 603-9 p. digitalISSN:- 0163-2116
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Carcinoma, Hepatocellular -- epidemiology
- Case-Control Studies
- Cohort Studies
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Resistance
- Female
- Glycyrrhizic Acid -- administration & dosage
- Hepatitis C, Chronic -- drug therapy
- Humans
- Incidence
- Injections, Intravenous
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Liver Function Tests
- Liver Neoplasms -- epidemiology
- Long-Term Care
- Male
- Middle Aged
- Multivariate Analysis
- Probability
- Prognosis
- Recombinant Proteins
- Retrospective Studies
- Risk Assessment
- Severity of Illness Index
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.